Hansa Biopharma to host Year-end report 2024 conference call
Lund, Sweden, January 23, 2025. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), will publish its year-end report for January-December 2024 on February 6, 2025. Interested parties may join the Company’s quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren Tulstrup, President and CEO, Evan Ballantyne, CFO, and Hitto Kaufmann, CR&DO. The call will include a review of the interim results and a business and pipeline update. It will be held in English. Slides used in the presentation will be made available on the company website at the